Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Pharmacokinetic–Pharmacodynamic Relationship: Problems

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

Bioequivalence of Drugs: Drugs with Multiple Indications

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reply to: Reassessing the evidence linking clinical leadership to AI deployment outcomes.

NPJ digital medicine·2026

Same author

An Artificial Intelligence-Enabled Cardiopulmonary Resuscitation Instructor.

JAMA internal medicine·2026

Same author

Identifying demographic predictors of increased non-fatal opioid overdose risk among New York State Medicaid enrollees following the COVID-19 pandemic: an analysis of heterogeneous treatment effects.

Epidemiology (Cambridge, Mass.)·2026

Same author

No Black Box Anymore: Demystifying Clinical Predictive Modeling with Temporal-Feature Cross Attention Mechanism.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

Same author

Benchmarking Waitlist Mortality Prediction in Heart Transplantation Through Time-to-Event Modeling using New Longitudinal UNOS Dataset.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026

Same author

Achieving health equity in immune disease: leveraging big data and artificial intelligence in an evolving health system landscape.

Frontiers in big data·2025

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Towards a collaborative filtering approach to medication reconciliation.

Sharique Hasan¹, George T Duncan, Daniel B Neill

¹The Heinz School, Carnegie Mellon University, Pittsburgh, PA, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium

|November 13, 2008

Summary

This study introduces a new method for detecting missing medications on patient lists by adapting online shopping

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 28, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

Health Informatics
Clinical Decision Support
Pharmacovigilance

Background:

Physician prescribing relies on accurate patient medication lists, which are often incomplete.
Incomplete medication lists can lead to adverse drug events.
Medication reconciliation is recommended to improve list accuracy.

Purpose of the Study:

To develop automated techniques for detecting omissions in patient medication lists.
To identify medications a patient may be taking but are not officially recorded.

Main Methods:

Adapted the collaborative filtering framework, commonly used in e-commerce.
Applied nearest neighbor and co-occurrence techniques to medication data.
Utilized medication data from a long-term care center.

Main Results:

Preliminary results indicate the collaborative filtering approach is effective.
Demonstrated the potential for automated omission detection.
Identified specific drugs potentially missed in patient records.

Conclusions:

The collaborative filtering framework shows promise as a tool for medication reconciliation.
Automated detection of medication omissions can enhance patient safety.
This approach can improve the accuracy of patient medication lists.